A distinct plasma lipid signature associated with poor prognosis in castration-resistant prostate cancer.
Lin HM, Mahon KL, Weir JM, Mundra PA, Spielman C, Briscoe K, Gurney H, Mallesara G, Marx G, Stockler MR, PRIMe Consortium, Parton RG, Hoy AJ, Daly RJ, Meikle PJ, Horvath LG.
Lin HM, et al. Among authors: gurney h.
Int J Cancer. 2017 Nov 15;141(10):2112-2120. doi: 10.1002/ijc.30903. Epub 2017 Aug 8.
Int J Cancer. 2017.
PMID: 28741687